Cellular pathway yields potential new weapon in vaccine arsenalDecember 27, 2006When a cell has to destroy any of its organelles or protein aggregates, it envelopes them in a membrane, forming an autophagosome, and then moves them to another compartment, the lysosome, for digestion. Two years ago, Rockefeller University assistant professor Christian Münz showed that this process, called autophagy, sensitizes cells for recognition by the immune system's helper T cells. But he didn't know how often this pathway is used or how efficient it is. Now, a new study published online this week in the journal Immunity goes a long way toward addressing these questions and shows that the pathway is so common that it could be a valuable new way of boosting vaccine efficacy. There are two types of T cells: Helper T cells encourage their counterpart, killer T cells, to hunt down and attack invading pathogens. T cells typically recognize antigens only once they're presented to them by major histocompatibility compex (MHC) scaffolding molecules on a cell's surface. Antigens on MHC class I molecules are recognized by killer T cells and had originally been thought to come only from sources inside a cell (proteins from the nucleus or other cellular part); those on MHC class II molecules are recognized by helper T cells and had been thought to come from sources outside the cell, such as fragments of dead, infected cells. But as Münz discovered two years ago, an autophagy pathway allows intracellular antigens to be presented on MHC class II molecules. Now Münz, head of Rockefeller's Laboratory of Viral Immunobiology, and Dorothee Schmid, a graduate fellow in the lab, have shown that the autophagy pathway is far more widespread than they thought: They found that a surprising number of cells with MHC class II molecules on their surfaces used the autophagy pathway. In skin (epithelial) cells and two other types of immune cells (dendritic and B cells), 50 to 80 percent of the autophagosomes moved into the loading compartment for MHC class II molecules. "For types of cells that upregulate MHC class II upon inflammation - epithelial cells of infected organs, for instance - one could assume that they might actually use the autophagy pathway fairly frequently," Münz says. Then, to test the pathway's effectiveness, the researchers targeted an influenza antigen directly to autophagosomes. They found that they were able to increase antigen presentation by MHC class II molecules, subsequently boosting helper T cell recognition of viral antigens. "This targeting pathway could be very efficient for vaccine development," Münz says, especially for recombinant viral vaccines like those against HIV. "Killer T cell responses are usually short-lived. But if you can increase recognition by helper T cells, then you'll be more likely to maintain the killer T cell response and establish immunological memory." The Rockefeller University |
|||||||||||||||||||||
| Related Cellular Pathway Current Events and Cellular Pathway News Articles UAB research could boost coastal economics with crustacean molting on demand University of Alabama at Birmingham (UAB) researchers are close to unraveling intricate cellular pathways that control molting in blue crabs. The discoveries could revolutionize the soft-shell crab industry, generating new jobs and additional profits for the U.S. fishing industry along the coastal Southeast. Alcohol activates cellular changes that make tumor cells spread Alcohol consumption has long been linked to cancer and its spread, but the underlying mechanism has never been clear. Probiotic Found to Be Effective Treatment for Colitis In Mice The probiotic, Bacillus polyfermenticus, can help mice recover from colitis, a new study has found. UCSF researchers program cells to be remote-controlled by light UCSF researchers have genetically encoded mouse cells to respond to light, creating cells that can be trained to follow a light beam or stop on command like microscopic robots. Injection reverses heart-attack damage Injured heart tissue normally can't regrow, but researchers at Children's Hospital Boston have now laid the groundwork for regenerating heart tissue after a heart attack, in patients with heart failure, or in children with congenital heart defects. Cell pathway on overdrive prevents cancer response to dietary restriction Whitehead Institute researchers have pinpointed a cellular pathway that determines whether cancerous tumors are susceptible to dietary restriction during their development. Tuning in on cellular communication in the fruit fly In their ongoing study of the processes involved in embryonic development in fruit flies, researchers at WPI's Life Sciences and Bioengineering Center at Gateway Park have identified the function of a protein that sticks out of the embryonic cell membrane like an antenna and processes signals needed for the flies' wings to develop properly. Researchers disrupt biochemical system involved in cancer, degenerative disease Screening a chemical library of 200,000 compounds, researchers at UT Southwestern Medical Center have identified two new classes that can be used to study and possibly manipulate a cellular pathway involved in many types of cancer and degenerative diseases. Snails and humans use same genes to tell right from left Biologists have tracked down genes that control the handedness of snail shells, and they turn out to be similar to the genes used by humans to set up the left and right sides of the body. Loss of sleep, even for a single night, increases inflammation in the body Loss of sleep, even for a few short hours during the night, can prompt one's immune system to turn against healthy tissue and organs. More Cellular Pathway Current Events and Cellular Pathway News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||